Consultation News and Research

RSS

Lineagen introduces FirstStep integrated genetic testing for early diagnostic evaluation of ASD, DD

Lineagen announces the launch of its FirstStep integrated genetic testing and counseling service to assist pediatricians and family physicians with the earlier, more accurate diagnostic evaluation of autism spectrum disorders and developmental delay.

11 Jan 2011

VEREGEN Ointment added as new therapeutic option in 2010 CDC STD Treatment Guidelines

PharmaDerm, a division of Nycomed US Inc., announced today that VEREGEN (sinecatechins) Ointment, 15%, a topical medication for the treatment of external genital and perianal warts, has been added as a new therapeutic option in the 2010 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.

6 Jan 2011

Today's Opinions: GOP rerun; Finding bipartisanship; Pawlenty's legacy

You just can't close the door on this crowd. The party that brought us the worst economy since the Great Depression, that led us into Iraq and the worst foreign policy disaster in American history, that would like to take a hammer to Social Security and a chisel to Medicare, is back in control of the House of Representatives with the expressed mission of undermining all things Obama (Bob Herbert, 1/3).

4 Jan 2011

New Year resolution: Cosmetic dentistry

This New Year, we can make the same tired resolutions -- start exercising, eat better, stop smoking -- or we can make a resolution that's actually attainable: Smile more. If those last two words send a chill up your spine, you're not alone, says Charles Martin DDS, founder of the Richmond Smile Center.

30 Dec 2010

ARYx provides additional clarification about operations

ARYx Therapeutics, Inc. today provided further clarification of its status as an operating company, including the on-going appointment of its officers on behalf of the Company. The NASDAQ Staff has requested additional clarification about the Company's operations in conjunction with their on-going consideration of the Company's eligibility for continued listing on The NASDAQ Capital Market.

24 Dec 2010

TFAH applauds Congress for final passage of FDA Food Safety Modernization Act of 2010

Trust for America's Health applauded Congress today for final passage of the FDA Food Safety Modernization Act of 2010. Because of the bill, the U.S. Food and Drug Administration will have the authority it needs to help prevent foodborne illnesses for the first time ever.

23 Dec 2010

10 guiding principles for strengthening health systems

Despite the growing recognition of the importance of strengthening health systems around the world, there is a considerable lack of shared definitions and guiding principles that are threatening the ability to form strategic policy, practice and evaluations.

22 Dec 2010

Dentists recognized for excellence in ethics, leadership and professionalism

Two local dentists were recently recognized for excellence in ethics, leadership and professionalism when they were invited to become Fellows of the American College of Dentists.

21 Dec 2010

Cholera deaths in Haiti top 2,500, health ministry says

The Haitian health ministry on Sunday said there had been 2,535 cholera deaths since the outbreak hit in mid-October, "dashing hopes the fatality rate might be beginning to taper off," Agence France-Presse reports.

21 Dec 2010

Exome sequencing leads to correct diagnosis and life-saving treatment for mysterious genetic disorder

A genetic testing approach called exome sequencing—which provides a clinically practical alternative to whole-genome sequencing—led to correct diagnosis and life-saving treatment in a child with a previously unknown genetic disease, reports an upcoming paper in Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics (ACMG). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

21 Dec 2010

SEEK announces new joint venture entity with Pernix Therapeutics for antitussive drug development

SEEK, a leading UK privately-owned drug-discovery group, is pleased to announce the establishment of a new joint venture entity with Pernix Therapeutics Holdings, an integrated specialty pharmaceutical company focused primarily on the United States pediatric market.

20 Dec 2010

Foster care standards formulated

Now all foster children in Australia for the first time will receive individual plans detailing the support they need after leaving care. This comes under the new national scheme wherein uniform standards in meeting each child’s requirements at the time of entering foster care will be ensured. At present child protection systems are different for each of the states and territories. This scheme will unite them all.

16 Dec 2010

BioPontis Alliance, Merck enter innovative strategic agreement in translational drug research

BioPontis Alliance, LLC announced today that it has entered into an innovative strategic agreement with Merck (known outside the US and Canada as MSD) designed to bridge the gap between early academic discovery science and the development of medicines and technologies that impact human health. The announcement was made this week at the prestigious Partnering For Cures Conference that is convened annually for the purpose of forging strategic cross-sector collaborations.

16 Dec 2010

Lilly suspends tasisulam global Phase III study in metastatic melanoma

Eli Lilly and Company announced today that it has suspended its global Phase III study evaluating tasisulam, an investigational, small-molecule anti-cancer compound, as a second-line treatment for those with unresectable or metastatic melanoma.

13 Dec 2010

Intercell to stop further development of Travelers' Diarrhea Vaccine Patch

Intercell AG announced today preliminary clinical results on its investigational Travelers' Diarrhea (TD) Vaccine Patch program and the decision not to pursue further the development of this vaccine candidate. The decision was made following the receipt of results of its randomized and placebo-controlled Phase III study (ELT301) with 2036 travelers from Europe to Mexico and Guatemala as well as the pilot efficacy Phase II trial (ELT209) with 723 travelers from Europe to India.

13 Dec 2010

Dogs help understand primary ciliary dyskinesia

A dog is mankind's best friend : the old saying has once again been borne out through a medical discovery concerning the genetic origins of primary ciliary dyskinesia (PCD). In using dogs as a research model in the framework of the European LUPA project, a team from the University of Liège's GIGA-Research Unit has been able to bring to light new mutations in a specific gene responsible for the development of the disease in human beings.

9 Dec 2010

Lung transplant saves economist from near-lethal bout of swine flu

According to the critical care experts at The Johns Hopkins Hospital who treated him, Allen Bagents, 24, of Arlington, Va., is the least likely person anyone ever expects to get sick, let alone suffer a six-week, potentially fatal bout with the swine flu, better known as H1N1 influenza.

8 Dec 2010

WHO endorses new rapid fully automated nucleic acid amplification test for TB

Today, WHO endorsed a new and novel rapid test for tuberculosis (TB), especially relevant in countries most affected by the disease. The test could revolutionize TB care and control by providing an accurate diagnosis for many patients in about 100 minutes, compared to current tests that can take up to three months to have results.

8 Dec 2010

CCS encourages CRD to support proposal on banning indoor tanning for youth under 18

The Canadian Cancer Society is encouraging the Capital Region District to support a proposal at their regular meeting tomorrow to ban indoor tanning for youth under 18. If approved, the CRD will become the first BC jurisdiction to take this step.

8 Dec 2010

School-based ASMA program helps adolescents improve asthma management, quality of life

A school-based intervention program designed for adolescents with asthma significantly improves asthma management and quality of life for the students who participate, and reduces asthma morbidity, according to researchers in New York City, who studied the effect of the program aimed at urban youth and their medical providers.

8 Dec 2010

Consultation News and Research

Lineagen introduces FirstStep integrated genetic testing for early diagnostic evaluation of ASD, DD

VEREGEN Ointment added as new therapeutic option in 2010 CDC STD Treatment Guidelines

Today's Opinions: GOP rerun; Finding bipartisanship; Pawlenty's legacy

New Year resolution: Cosmetic dentistry

ARYx provides additional clarification about operations

TFAH applauds Congress for final passage of FDA Food Safety Modernization Act of 2010

10 guiding principles for strengthening health systems

Dentists recognized for excellence in ethics, leadership and professionalism

Cholera deaths in Haiti top 2,500, health ministry says

Exome sequencing leads to correct diagnosis and life-saving treatment for mysterious genetic disorder

SEEK announces new joint venture entity with Pernix Therapeutics for antitussive drug development

Foster care standards formulated

BioPontis Alliance, Merck enter innovative strategic agreement in translational drug research

Lilly suspends tasisulam global Phase III study in metastatic melanoma

Intercell to stop further development of Travelers' Diarrhea Vaccine Patch

Dogs help understand primary ciliary dyskinesia

Lung transplant saves economist from near-lethal bout of swine flu

WHO endorses new rapid fully automated nucleic acid amplification test for TB

CCS encourages CRD to support proposal on banning indoor tanning for youth under 18

School-based ASMA program helps adolescents improve asthma management, quality of life

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News